Reaction profile
The FDA adverse-event record for ventricular arrhythmia
139 FDA adverse-event reports reference ventricular arrhythmia (VeDDRA 2222). Plate codes and volume neighbourhood below; species, breeds, and drugs follow.
- #1230 of 2,481
- by report volume (all reactions)
- 139
- reports citing this reaction
- 38.1%
- death-coded share
- Dog
- most-affected species
Release-over-release change
What changed in the latest FDA data snapshot
PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Ventricular arrhythmia has 139 reports now versus 139 in that prior snapshot: 0 the same number of (0.0%).
- Report change
- +0
- Death-coded reports
- +0
- Death-coded share
- −0.0 pts
This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.
Subscribe to Ventricular arrhythmia changesFDA AER · VeDDRA plate
Code 2222 VOL-LOW
VOL-LOW · DEATH-HOT · MID-PACK · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL
- VOL-LOW 139 reports
- DEATH-HOT 38.1%
- MID-PACK #1230/2481
- PHOTO-FINISH Haemolytic anaemia
- SPECIES-DOG Dog · 127
- DRUG-LEAD Dexmedetomidine H… · 22
- DESK-WIDE 20 breeds
- BOOK-FULL 8/8 fields
Nearest volume peer: Haemolytic anaemia (±0 reports)
Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.
Report-volume neighbourhood around Ventricular arrhythmia
Highest and lowest poles plus nearest volume peers, not a full 2,500-reaction corpus board reprint.
Ventricular arrhythmia: high death-coded share in the FDA AER plate
Signature read: Ventricular arrhythmia's 38.1% death-coded share is among the highest in the openFDA reaction corpus. Report volume sits in the middle third of the reaction corpus. Death-coded share is upper-third: 53 of 139 reports (38.1% of named reports). Nearest volume peer: Haemolytic anaemia (±0 reports). Lead species Dog (127). Lead co-reported drug Dexmedetomidine Hydrochloride (22).
Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.
Species Most Affected
Breeds Most Affected
Associated Drugs
Nationwide reactions with similar profiles
Two openFDA-derived peer sets for Ventricular arrhythmia, both floored at ≥50 reports so the neighborhoods stay in the advertised mass (the volume chart above is the unfloored photo-finish strip).
Similar report volume
Nearest other reactions by FDA report count (139 here).
Similar death-coded share
Nearest other reactions by death-coded share (38.1% here), distinct from the volume row.
What to do with this reaction
- Compare Ventricular arrhythmia's report profile against similar reactions nationwide. See similar reactions
- Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
- Browse the full reaction directory to compare report counts across reaction types. All reactions
A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →